0001821825-24-000079.txt : 20240611
0001821825-24-000079.hdr.sgml : 20240611
20240611151753
ACCESSION NUMBER: 0001821825-24-000079
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240607
FILED AS OF DATE: 20240611
DATE AS OF CHANGE: 20240611
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sharp Shalini
CENTRAL INDEX KEY: 0001377202
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40235
FILM NUMBER: 241035549
MAIL ADDRESS:
STREET 1: C/O ULTRAGENYX PHARMACEUTICAL INC.
STREET 2: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Organon & Co.
CENTRAL INDEX KEY: 0001821825
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 464838035
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 30 HUDSON STREET
STREET 2: FL 33
CITY: JERSEY CITY
STATE: NJ
ZIP: 07302
BUSINESS PHONE: 551-430-6000
MAIL ADDRESS:
STREET 1: 30 HUDSON STREET
STREET 2: FL 33
CITY: JERSEY CITY
STATE: NJ
ZIP: 07302
4
1
wk-form4_1718133465.xml
FORM 4
X0508
4
2024-06-07
0
0001821825
Organon & Co.
OGN
0001377202
Sharp Shalini
C/O ORGANON & CO.
30 HUDSON STREET, FLOOR 33
JERSEY CITY
NJ
07302
1
0
0
0
0
Phantom Stock
2024-06-07
4
A
0
9638.554
20.75
A
Common Stock
9638.554
36783.9
D
Each phantom stock unit is an economic equivalent of one share of Organon & Co. ("Organon") common stock, or 1-for-1.
Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan.
Holdings include phantom stock acquired in dividend reinvestment transactions on June 15, 2023, September 14, 2023, December 14, 2023 and March 14, 2024.
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Shalini Sharp
2024-06-11